These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 4729901)
1. Intravenous clonidine in hypertensive patients. Mroczek WJ; Davidov M; Finnerty FA Clin Pharmacol Ther; 1973; 14(5):847-51. PubMed ID: 4729901 [No Abstract] [Full Text] [Related]
2. Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension. Lund-Johansen P Acta Med Scand; 1974; 195(1-2):111-5. PubMed ID: 4817078 [No Abstract] [Full Text] [Related]
3. Haemodynamic changes in long-term therapy of essential hypertension: a comparative study of diuretics, alpha-methyldopa and clonidine. Lung-Johansen P Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():199s-203. PubMed ID: 4593565 [No Abstract] [Full Text] [Related]
4. [Clonidine in the management of hypertensive crisis (author's transl)]. Esser H; Kikis D; Stumpe KO; Krück F Dtsch Med Wochenschr; 1980 Jan; 105(1):11-5. PubMed ID: 7351163 [TBL] [Abstract][Full Text] [Related]
5. Haemodynamic and endocrine changes during anti-hypertensive treatment with clonidine and its derivative St 600. Kho TL; Zaal GA; Wester A; de Leeuw PW; Birkenhäger WH Clin Sci Mol Med Suppl; 1976 Dec; 3():641s-643s. PubMed ID: 1071697 [TBL] [Abstract][Full Text] [Related]
7. [General principles of antihypertensive treatment]. Lagrue G; Weil B; Buisson C Sem Hop; 1974 Feb; 50(8):561-6. PubMed ID: 4152683 [No Abstract] [Full Text] [Related]
8. Changes in cardiac function after effective treatment of hypertensive emergencies with i.v. clonidine. Masotti G; Scarti L; Poggesi L; Bisi G; Gallini C; Neri Serneri GG Eur Heart J; 1984 Dec; 5(12):1036-42. PubMed ID: 6534750 [TBL] [Abstract][Full Text] [Related]
9. Clonidine and guanfacine--comparison of their effects on haemodynamics in hypertension. Seedat YK S Afr Med J; 1985 Apr; 67(14):557-9. PubMed ID: 3887593 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935). Wellens D; Snoeckx L; De Reese R; Kruger R; Van de Water A; Woutens L; Reneman RS Arch Int Pharmacodyn Ther; 1975 May; 215(1):119-32. PubMed ID: 1156041 [TBL] [Abstract][Full Text] [Related]